M50 drug refers to Sitasentro-M50 Tablet, a combination medication used to treat type II diabetes.
Understanding Sitasentro-M50
Sitasentro-M50 is an anti-diabetic medication containing two active ingredients:
- Sitagliptin: A DPP4 (dipeptidyl peptidase-4) inhibitor.
- Metformin: A biguanide.
This combination helps to control blood sugar levels in patients with type II diabetes.
How it Works
- Sitagliptin (DPP4 Inhibitor): DPP-4 inhibitors work by blocking the action of the DPP-4 enzyme, which inactivates incretin hormones. Incretin hormones help the body release insulin after a meal and reduce the amount of glucose produced by the liver. This action results in lowered blood sugar levels.
- Metformin (Biguanide): Metformin primarily works by decreasing glucose production in the liver and improving the body's sensitivity to insulin. It also reduces the amount of glucose absorbed from the intestines.
Key Points
- Sitasentro-M50 is a combination drug.
- It is used to treat type II diabetes.
- It contains Sitagliptin and Metformin.
